KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Equity Ratio (2018 - 2025)

ClearPoint Neuro's Equity Ratio history spans 13 years, with the latest figure at 0.26 for Q3 2025.

  • For Q3 2025, Equity Ratio fell 63.55% year-over-year to 0.26; the TTM value through Sep 2025 reached 0.26, down 63.55%, while the annual FY2024 figure was 0.65, 30.54% up from the prior year.
  • Equity Ratio for Q3 2025 was 0.26 at ClearPoint Neuro, down from 0.31 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.74 in Q4 2021 and bottomed at 0.26 in Q3 2025.
  • The 5-year median for Equity Ratio is 0.65 (2024), against an average of 0.61.
  • The largest annual shift saw Equity Ratio surged 9316.08% in 2021 before it plummeted 63.55% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.74 in 2021, then fell by 10.64% to 0.66 in 2022, then decreased by 25.34% to 0.5 in 2023, then surged by 30.54% to 0.65 in 2024, then tumbled by 59.4% to 0.26 in 2025.
  • Per Business Quant, the three most recent readings for CLPT's Equity Ratio are 0.26 (Q3 2025), 0.31 (Q2 2025), and 0.66 (Q1 2025).